0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessA TACE-specific and extensively validated model based on routinely available clinical features and response after first TACE permitted patient-level prognostication.
Guohong Han, Sarah Berhane, Hidenori Toyoda, Dominik Bettinger, Omar Elshaarawy, Anthony W.H. Chan, Martha M. Kirstein, Cristina Mosconi, Florian Hucke, Daniel H. Palmer, David J. Pinato, Rohini Sharma, Diego Ottaviani, Jeong Won Jang, Tim A. Labeur, Otto M. van Delden, Mario Pirisi, Nick Stern, Bruno Sangro, Tim Meyer, Waleed Fateen, Marta García‐Fiñana, Asmaa Gomaa, Imam Waked, Eman Rewisha, Guruprasad P. Aithal, Simon Travis, Masatoshi Kudo, Alessandro Cucchetti, Markus Peck‐Radosavljevic, R. Bart Takkenberg, Stephen L. Chan, Arndt Vogel, Philip J. Johnson (2019). Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach. , 72(1), DOI: https://doi.org/10.1002/hep.31022.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2019
Authors
34
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1002/hep.31022
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
